UCSF

ZINC04340269

Substance Information

In ZINC since Heavy atoms Benign functionality
November 21st, 2005 15 No

Other Names:

17440-83-4 (hydrochloride)

17440-83-4; Amiloride hydrochloride (USP); D00649; Midamor (TN)

17440-83-4; Amiloride hydrochloride dihydrate; Prestwick_15

1f5l

2016-88-8 (anhydrous hydrochloride)

2609-46-3

2609-46-3; Amiclaran (TN); Amiloride (INN); D07447

2609-46-3; Amiloride; C06821

3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide

3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide

3,5-Diamino-N-(aminomethyl)-6-chloropyrazine carboxamide hydrochloride dihydrate

3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide

3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide dihydrate hydrochloride

3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; Amiloride; N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide

3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide

AB00053415

AC-13631

AC1L27IZ

AC1Q3POC

Amiclaran

Amiclaran (TN)

Amikal (Hydrochloride dihydrate)

Amilorid hydrochlorid-2-wasser

Amilorida

Amilorida [INN-Spanish]

Amilorida [INN-Spanish];Amiloride hydrochloride hydrate;Amiloridum [INN-Latin];Amyloride

amilorida; amiloride; amiloridum

Amiloride

Amiloride (BAN

Amiloride (INN)

AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8))

AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8)); Amilorida [INN-Spanish]; Amiloride; Amiloride [INN:BAN]; Amiloridum [INN-Latin]; Amipramidin; Amipramizid; C6H8ClN7O; CCRIS 6545; EINECS 220-024-7; Guanamprazin; LS-1094; Midamor; N-Amidino-3,5-diamino-6-ch

Amiloride HCl

Amiloride HCl dihydrate

AMILORIDE HCL; AMILORIDE HCL AND HYDROCHLOROTHIAZIDE; AMILORIDE HYDROCHLORIDE; Amilorid hydrochlorid-2-wasser; Amiloride hydrochloride [USAN]; Amiloride hydrochloride dihydrate; C6H8ClN7O.HCl; Frumil; HYDRO-RIDE; LS-173667; MIDAMOR; MK 870; MODURETIC 5-50

Amiloride Hydrochloride

Amiloride hydrochloride (Midamor)

Amiloride hydrochloride dihydrate

Amiloride hydrochloride hydrate

Amiloride [INN:BAN]

Amiloridehydrochloride

Amiloridehydrochloridedihydrate

Amiloridum

Amiloridum [INN-Latin]

Amiloridum [INN-Latin]; Amiloride hydrochloride hydrate; Amilorida [INN-Spanish]; Amyloride

Amiloridum [INN-Latin];Amiloride hydrochloride hydrate;Amilorida [INN-Spanish];Amyloride

Amipramidin

Amipramidin; Amipramizid; Amipramizide; CPD-10324; Guanamprazin; Guanamprazine; Midamor; amiloride

Amipramizid

Amipramizide

Amiprazidine

AMR

Amyloride

BCBcMAP01_000101

BIDD:GT0466

Bio1_000359

Bio1_000848

Bio1_001337

Bio2_000292

Bio2_000772

BPBio1_000015

BRD-K97181089-003-02-3

BRD-K97181089-310-03-0

BSPBio_000013

BSPBio_001572

BSPBio_001826

C06821

C6H8ClN7O

CCRIS 6545

CHEBI:2639

CHEBI:47210

CHEMBL945

CID16231

CPD-10324

CPD000449325; Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro- [CAS]

CPD000449325; Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro- [CAS]; SAM001246996

D07447

DAP000187

DB00594

DivK1c_000182

EINECS 220-024-7

Guanamprazin

Guanamprazine

HMS1791O14

HMS1989O14

HMS2089H05

IDI1_000182

IDI1_034042

INN); Amiloride HCl (FDA

INN); Amiloride Hydrochloride (FDA

KBio1_000182

KBio2_000292

KBio2_000394

KBio2_002860

KBio2_002962

KBio2_005428

KBio2_005530

KBio3_000583

KBio3_000584

KBio3_001326

KBioGR_000292

KBioGR_000544

KBioSS_000292

KBioSS_000394

LS-1094

LS-190461

MFCD00058197

MFCD00069211

MFCD00077316

MFCD00211292

MFCD03703482

Midamor

Midamor (Hydrochloride dihydrate)

Midamor, Colectril, Amipramizide, Guanamprazine hydrochloride

MK-870 (Hydrochloride dihydrate)

MLS000758249

MLS001060798

Modamide

MolPort-005-934-472

MolPort-005-937-651

N-(3,5-Diamino-6-chloro-pyrazine-2-carbonyl)-guanidine

N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide

N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride

N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid

N-Amido-3,5-diamino-6-chloropyrazine carboxamide

N-Amido-3,5-diamino-6-chloropyrazine carboxamide hydrochloride dihydrate

N/A

NCGC00015089-01

NCGC00015089-02

NCGC00015089-12

NCGC00024443-02

NCGC00024443-05

NCGC00024443-06

NCGC00024443-07

NCGC00024443-09

NINDS_000182

Prestwick0_000007

Prestwick1_000007

Prestwick2_000007

Prestwick3_000007

Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-

Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride

QA-6333

SMR000449325

SMR000486264

SPBio_000136

SPBio_001934

Spectrum2_000118

Spectrum3_000293

Spectrum4_000132

Spectrum5_000776

Spectrum_000034

ST079279

Tocris-0890

UNII-7DZO8EB0Z3

USAN

USAN)

USP

USP)

ZINC04340269

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -1.37 -3.38 -10.68 8 8 0 159 229.631 1
Hi High (pH 8-9.5) -1.37 -3.35 -39.89 7 8 -1 157 228.623 1

Vendor Notes

Note Type Comments Provided By
mechanism . ZereneX Building Blocks
ALOGPS_SOLUBILITY 1.22e+00 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
MP >240° Oakwood Chemical
UniProt Database Links ADA2A_PIG; AOC1_HUMAN; AOC1_MOUSE; AOC1_PIG; AOC1_RAT; AOCX_BOVIN; AOCY_BOVIN; DEG1_CAEEL; DEGZ_CAEEL; DEL1_CAEEL; FANA_HELAS; GLIC_GLOVI; LODA_MARM1; MEC10_CAEBR; MEC10_CAEEL; MEC4_CAEBR; MEC4_CAEEL; MEC6_CAEEL; NACH_DROAN; NACH_DROME; NACH_DROVI; NHAA_V ChEBI
mechanism Amiloride exerts its potassium sparing effect through the inhibition of sodium reabsorption at the distal convoluted tubule, cortical collecting tubule and collecting duct IBScreen Bioactives
mechanism Amiloride is not an aldosterone antagonist and its effects are seen even in the absence of aldosterone. IBScreen Bioactives
Indications cystic fibrosis KeyOrganics Bioactives
Patent Database Links EP0795327; EP1106210; EP1634607; EP1695716; EP1717226; EP1731140; EP1767534; EP1839648; EP1844774; EP1862181; EP1908834; EP1941883; EP1967192; GB2264710; US2002115655; US2004147575; US2005009870; US2005014786; US2005043325; US2005080087; US2005187267; US2 ChEBI
Patent Database Links EP1553091; US2005059655; US2006189603; US2007037821; US2007238740; US2008275093; US2008287407; US2008293678; US2008293702; WO2005018561; WO2005023183; WO2005030135; WO2005060603; WO2006055542; WO2006078995; WO2006091716; WO2006093864; WO2006099058; WO2006 ChEBI
Therapy Epithelial Na+ channel blocker SMDC Iconix
mechanism Inhibitor of sodium reabsorption in the distal convoluted tubules and collecting ducts in the kidneys by binding to the amiloride-sensitive sodium channels. IBScreen Bioactives
therap Na+ channel inhibitor, diuretic MicroSource Spectrum
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 101735; 2 water; 1 hydrogen chloride NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
biological_use Potassium-sparing diuretic IBScreen Bioactives
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 101735; SALT: 2 water; 1 hydrogen chloride NIH Clinical Collection via PubChem
Target Sodium Channel,Calcium Channel Selleck Chemicals
mechanism this decreases the net negative potential of the tubular lumen and reduces both potassium and hydrogen secretion and their subsequent excretion. IBScreen Bioactives
mechanism This promotes the loss of sodium and water from the body, but without depleting potassium. IBScreen Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
AA2AR-1-E Adenosine A2a Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 3280 0.51 Binding ≤ 10μM
ACCN3-1-E Amiloride-sensitive Cation Channel 3 (cluster #1 Of 2), Eukaryotic Eukaryotes 4400 0.50 Binding ≤ 10μM
AOC3-2-E Amine Oxidase, Copper Containing (cluster #2 Of 2), Eukaryotic Eukaryotes 10000 0.47 Binding ≤ 10μM
SCNNA-1-E Amiloride-sensitive Sodium Channel Alpha-subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 776 0.57 Binding ≤ 10μM
UROK-4-E Urokinase-type Plasminogen Activator (cluster #4 Of 4), Eukaryotic Eukaryotes 7000 0.48 Binding ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 7943 0.48 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
SCNNA_HUMAN P37088 Amiloride-sensitive Sodium Channel Alpha-subunit, Human 776 0.57 Binding ≤ 1μM
AA2AR_HUMAN P29274 Adenosine A2a Receptor, Human 3280 0.51 Binding ≤ 10μM
ACCN3_HUMAN Q9UHC3 Amiloride-sensitive Cation Channel 3, Human 4400 0.50 Binding ≤ 10μM
SCNNA_HUMAN P37088 Amiloride-sensitive Sodium Channel Alpha-subunit, Human 776 0.57 Binding ≤ 10μM
AOC3_RAT O08590 Amine Oxidase, Copper Containing, Rat 10000 0.47 Binding ≤ 10μM
UROK_HUMAN P00749 Urokinase-type Plasminogen Activator, Human 2511.88643 0.52 Binding ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 7943.28235 0.48 Functional ≤ 10μM

Direct Reactome Annotations (via ChEBI)

Description Species
Stimuli-sensing channels

Reactome Annotations from Targets (via Uniprot)

Description Species
Adenosine P1 receptors
Dissolution of Fibrin Clot
G alpha (s) signalling events
NGF-independant TRKA activation
Stimuli-sensing channels

Analogs ( Draw Identity 99% 90% 80% 70% )